Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in non-obese diabetic mice.
about
The novel chemokine receptor, G-protein-coupled receptor 75, is expressed by islets and is coupled to stimulation of insulin secretion and improved glucose homeostasisNaturally occurring anthraquinones: chemistry and therapeutic potential in autoimmune diabetesWhere CD4+CD25+ T reg cells impinge on autoimmune diabetesChronic insulin treatment of diabetes does not fully normalize alterations in the retinal transcriptome.In situ recognition of autoantigen as an essential gatekeeper in autoimmune CD8+ T cell inflammationMemory T cells migrate to and reject vascularized cardiac allografts independent of the chemokine receptor CXCR3.CCR7 directs the recruitment of T cells into inflamed pancreatic islets of nonobese diabetic (NOD) mice.RANTES (CCL5) reduces glucose-dependent secretion of glucagon-like peptides 1 and 2 and impairs glucose-induced insulin secretion in mice.Alloantigen-enhanced accumulation of CCR5+ 'effector' regulatory T cells in the gravid uterus.Expression and regulation of chemokines in murine and human type 1 diabetes.Catenarin Prevents Type 1 Diabetes in Nonobese Diabetic Mice via Inhibition of Leukocyte Migration Involving the MEK6/p38 and MEK7/JNK Pathways.Decreased Circulating Levels of APRIL: Questioning Its Role in Diabetes.Fibronectin receptor defects in NOD mouse leucocytes: possible consequences for type 1 diabetes.SENP1-mediated NEMO deSUMOylation in adipocytes limits inflammatory responses and type-1 diabetes progressionChemokines and their receptors in islet allograft rejection and as targets for tolerance induction.Functional redundancy of CXCR3/CXCL10 signaling in the recruitment of diabetogenic cytotoxic T lymphocytes to pancreatic islets in a virally induced autoimmune diabetes modelThe role of adipose-derived inflammatory cytokines in type 1 diabetesPromiscuous drugs as therapeutics for chemokine receptors.T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous eventChemokines, chemokine receptors and CD4+CD25+ regulatory T cells.Targeting CCL5 in inflammation.Advances in understanding the pathogenesis of autoimmune disorders: focus on chemokines and lymphocyte trafficking.Mechanisms of diabetic autoimmunity: II--Is diabetes a central or peripheral disorder of effector and regulatory cells?Mechanisms of diabetic autoimmunity: I--the inductive interface between islets and the immune system at onset of inflammation.Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation.Pancreatic β-Cell production of CXCR3 ligands precedes diabetes onset.The non-canonical NF-κB pathway is induced by cytokines in pancreatic beta cells and contributes to cell death and proinflammatory responses in vitro.Neutralization Versus Reinforcement of Proinflammatory Cytokines to Arrest Autoimmunity in Type 1 Diabetes.CCR2 and CCR5 chemokine receptors differentially influence the development of autoimmune diabetes in the NOD mouse.Cutting Edge: Origins, Recruitment, and Regulation of CD11c+ Cells in Inflamed Islets of Autoimmune Diabetes Mice.Transgenic expression of murine chemokine decoy receptor D6 by islets reveals the role of inflammatory CC chemokines in the development of autoimmune diabetes in NOD mice.Carbon monoxide-treated dendritic cells decrease β1-integrin induction on CD8+T cells and protect from type 1 diabetes
P2860
Q24319758-C4AF2EDF-210C-4A55-B8A0-B3BAC91D4D19Q27022572-0F73AD0F-5B60-4EA4-A366-08D4CF859643Q28506933-B6EDF376-1A60-4F71-A7F0-5959F81A52EDQ33901377-F8F8CF90-A102-4862-A2D8-B6FCBB8C7900Q33927309-ADE3D6B3-794B-4388-9DDB-FF4DCF69815FQ34774608-2A7791AA-627F-424A-B44D-DEE471A2856CQ35136409-0B29AC5F-3CF7-442E-BEB0-0DAC7A700CDDQ35175990-35CB99C9-B180-4A4C-9DD5-EFA5E7D7111BQ35578769-C2F1190B-7E71-46CA-97BD-BAA46AE02207Q35696643-0D4BA213-3012-4EE0-B722-2BA1EF9BBC43Q35793015-194A6CD6-C23D-40AA-8E61-238248B1F6B9Q35808734-2D4C1BFF-5551-4127-A3D6-6FA9EBDD15ECQ35828157-FB9E263F-4D7E-466B-844C-443E8E113251Q36325236-5139AAA0-2A2B-4E72-8439-1E43183337B0Q36560836-6BC5AFA5-E897-49FE-80BF-5EA35A6FC4D3Q37014873-65408D61-3F24-497A-85C2-876FBC37A46CQ37238016-1A4DA898-4589-40FE-91CA-F1F02EFF2195Q37362453-D417E49F-CC21-4C7B-838A-C71C8C3AC1BEQ37389695-2FEA51CA-3C88-4182-AFBB-72B9F870DE1FQ37755313-B1F90AEC-9026-4616-84C2-A366E5B5DFB7Q38148785-892AEE42-BBC8-47D9-89F8-3F80685FC7E2Q38155907-1038CA99-B6B1-450C-872F-C6ACBB8ACBFDQ38611317-DB179691-A832-45A6-B476-6D6E556C6828Q38660197-924BE5B3-57C0-4866-B522-8ED0327330B5Q38691482-4CF34F69-3E3D-4D90-AE60-FEC16E3848FAQ38763137-BAD106C1-D74D-4B4C-9518-237BBF28579AQ38814499-FA1BFADF-DA0E-4F3A-A597-D1025E94A462Q38966071-3F44F028-EA3B-4776-ABF1-0794A0F07707Q45748156-914695C1-B6A6-4418-91A4-AE1599B73199Q46511703-84468A4B-8DA5-4692-9972-1731AFBA7D35Q54374602-37338A11-8290-402E-A161-0045C6907B14Q58158657-562E36CC-CCA4-4B27-B885-F5BEF25D5306
P2860
Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in non-obese diabetic mice.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Leukocyte attraction through t ...... es in non-obese diabetic mice.
@en
Leukocyte attraction through t ...... es in non-obese diabetic mice.
@nl
type
label
Leukocyte attraction through t ...... es in non-obese diabetic mice.
@en
Leukocyte attraction through t ...... es in non-obese diabetic mice.
@nl
prefLabel
Leukocyte attraction through t ...... es in non-obese diabetic mice.
@en
Leukocyte attraction through t ...... es in non-obese diabetic mice.
@nl
P2093
P50
P356
P1476
Leukocyte attraction through t ...... tes in non-obese diabetic mice
@en
P2093
André Ballesteros
Angel Zaballos
Carla Carvalho-Pinto
Carlos Martínez-A
Juana M Flores
Lucio Gómez
María I García
P304
P356
10.1002/EJI.200324285
P407
P577
2004-02-01T00:00:00Z